Skip to main content

Table 3 Multivariate analysis for OS

From: Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

  P Value 95% CI
Lower Upper
Bevacizumab administration .134 .309 1.169
ECOG score .271 719 3.231
Surgery .008 1.287 5.201
Age > 65 .732 .632 1.921
NLR .569 .632 2.302
FIGO stage .784 .859 1.122